Cannabist (CBSTF) Stock Price, News & Analysis

Company Overview

The Cannabist Company Holdings Inc. engages in the cultivation, development, production, home delivery, and dispensary of cannabis products in the United States and internationally. The company provides flower, concentrates, edibles, and/or accesories, and medicinal cannabinoid capsules and tablets, as well as confections, chocolate, drink mixes, condiments, kief, shatter, and wax/crumble, under the Seed & Strain, Classix, and Triple Seven brand names. It offers management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in New York, New York.

Key Stats

• Today's Range: $0.10 to $0.12
• 50-Day Range: $0.10 to $0.25
• 52-Week Range: $0.09 to $0.62
• Volume: 734,732 shs
• Average Volume: 1.00 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $0.75
• Consensus Rating: Moderate Buy

CBSTF Stock Analysis - Frequently Asked Questions

How have CBSTF shares performed this year?

Cannabist's stock was trading at $0.2671 at the beginning of 2024. Since then, CBSTF stock has decreased by 60.6% and is now trading at $0.1052.
View the best growth stocks for 2024 here.

How do I buy shares of Cannabist?

Shares of CBSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:CBSTF
• CUSIP: N/A
• CIK: 1776738
• Web: www.cannabistcompany.com
• Phone: 212-634-7100
• Fax: N/A
• Employees: 2,590
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $0.75
• High Stock Price Target: $0.75
• Low Stock Price Target: $0.75
• Potential Upside/Downside: +613.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A